NDAIRRIGATIONSOLUTION
Approved
Nov 1969
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
3/8 — Basic
RESECTISOL (mannitol) by B. Braun is osmotic activity [moa]. First approved in 1969.
Drug data last refreshed 2d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
RESECTISOL (mannitol) is an osmotic diuretic solution administered via irrigation for multiple clinical indications including cystic fibrosis, elevated intracranial pressure, traumatic brain injury, and bowel preparation. It works by creating an osmotic gradient that draws fluid into the target tissue or lumen, reducing pressure or facilitating cleansing.
LOE Approaching
As an older NDA approaching LOE with minimal direct career pipeline signals, RESECTISOL roles are likely concentrated in niche commercial and medical affairs functions.
Mechanism of Action
Osmotic Activity
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
Inhaled Mannitol on Mucociliary Clearance in Moderate to Severe Cystic Fibrosis
Started Mar 2023
14 enrolled
Cystic Fibrosis
PT027 Compared to PT007 in Patients With Asthma With Mannitol-induced Acute Airway Obstruction
Started Sep 2022
190 enrolled
Asthma
Mannitol-Induced Cough Challenge in Healthy Controls and Subjects With Mild Allergic Asthma
Started Jan 2019
40 enrolled
AsthmaCough
A Study Comparing Picoprep With Mannitol and Bisacodyl for Colon Cleansing in Preparation for Colonoscopy
Started Feb 2015
184 enrolled
Bowel Preparation
A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects
Started Sep 2014
423 enrolled
Cystic Fibrosis
Worked on RESECTISOL at B. Braun? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.